ClinicalTrials.gg
RecruitingNCT07483515B³Updated Nov 6, 2026

Bonding Before Birth: A mHealth Intervention for First-time Expectant Couples

An interventional study of Group B (Intervention) in Anxiety, Pregnancy and Parenting Self-efficacy, sponsored by Institute for Human Development and Potential (IHDP), Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Institute for Human Development and Potential (IHDP), Singapore · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 6, 2026Start date movedPrimary outcomes revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
572
Allocation
Randomized
Ages
21 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Depression with a site in Singapore — 14 open to participants now, 18 under way, none of them phase 3. Depression · Singapore.

Planned enrollment
2nd of 25
572 · median 122
Started
2026
with 4 others
No phase
23 of 34
11 open now
Primary completion
2028-12
later than 15 of 17 live
Registered
28th of 34
by date
Lead sponsor
1 of 34
Institute for Human Development and Potential (IHDP), Singapore

Among the 34 studies in Depression with a site in Singapore, this one is the 2nd largest by planned enrollment of the 25 interventional ones that give a count, is one of 5 that started in 2026, is one of 23 with no phase, reaches primary completion later than 15 of the 17 other live ones, and was the 28th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

14 of the 34 studies in Depression with a site in Singapore are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 21 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Depression with a site in Singapore, or all of them as a file.
02

Study summary

Emotional regulation is a key component of reducing parenting stress, a sense of self-efficacy, and thus successful parenting, child outcomes, and productivity amongst working parents. However, few interventions begin building these necessary components in pregnancy prior to the extremely stressful period immediately post-partum, where little trait and behavioural modification occurs. More importantly, most interventions overlook the importance of having both partners, despite fathers/partners playing a significant role in influencing maternal stress and mood symptoms.

This goal of this study is to examine whether short weekly exercises delivered through a mobile app can help first-time parents feel better emotionally during pregnancy. These exercises are designed to help people manage their emotions and stress. Researchers want to know if doing these exercises, along with getting weekly feedback and encouragement, can reduce signs of depression and improve emotional control.

Expecting mothers and fathers who are having their first child may be able to join the study if they meet certain conditions. Participants should be planning to stay in Singapore for the next two years and be comfortable using a smartphone and answering questions in English. Participants may benefit from learning new ways to manage stress and emotions, which could help improve their mental health.

Participants will wear a Fitbit watch to track activity. They will complete a short weekly survey about their well-being during pregnancy and a monthly survey about their work productivity until six months after the baby is born. They will also answer online surveys about their health, relationships, and background at the start, three times during pregnancy, and three times after birth. In addition, they will visit the research lab twice to take part in tasks that measure thinking and behaviour.

Read the detailed description

The overall goal of this study is to answer the following main questions:

  • Does the intervention improve parents' depressive symptoms scores, using the Edinburgh Postnatal Depression Scale as a proxy?
  • Does the intervention improve parents' emotional regulation skills?

The study involves 286 expectant couples (572 individuals) in a two-arm, cluster-randomized controlled trial with longitudinal observational follow-up until the child turns 6 months old. The active intervention comprises of customized, weekly recommendations of short (2-5 minute) audio clips featuring activities such as breathing exercises, meditation, mindful walking. These will be provided to adult participants (expectant couples). Couples enrolling in the study will randomly be allocated to either the control or intervention group by prespecified block sizes of 10. That is, a random number generator will be used to preset the assignments in groups of 10, such that every 10 consecutive enrolments will have exactly 5 controls and 5 interventions (1:1 allocation). While it is not possible to blind operational staff to assignments (different protocols to follow, highly unbalanced assignment), scheduling of enrolment visits will be done by different staff than those conducting the enrolment visits, and the assignment will only be made known to enrolment staff while conducting the visit itself and they will also not have access to the blocking and randomization algorithm.

Participants in the control, no-intervention group will have access to a mobile app with similar functions as the participants in the intervention group, except that no personalized modules are given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

Participants in the intervention group will have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Participants will also be re-randomized weekly to different modules within the app. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

The intervention will take place throughout pregnancy, beginning at enrollment ( when the mother is less than 20 gestational weeks of pregnancy), and continuing until the child is born. As gestational duration varies among participants, the total intervention period will range approximately from 17 to 28 weeks, depending on the timing of recruitment and delivery. All study arms will be assessed up to 6 months after birth.

03

Conditions studied

  • Anxiety
  • Pregnancy
  • Parenting Self-efficacy
  • Stress (Psychology)
  • Depression
  • Emotion Regulation

Browse trials for

Keywords

  • Reinforcement Learning
  • Micro-randomization
  • Emotion Regulation
  • Depression
  • Pregnancy
  • Anxiety
04

In context

Depression Reclassified

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

This study's planned enrollment of 572 is above the median of 81 across 7,089 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Institute for Human Development and Potential (IHDP), Singapore is the lead sponsor of 24 studies on the registry; 6 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Mothers:

  1. 21-50 years of age
  2. Less than 20 weeks of pregnancy, confirmed by ultrasonography upon enrolment
  3. Singleton pregnancy
  4. Nulliparous
  5. Plan to deliver in Singapore
  6. Proficient and able to respond to questionnaires in English
  7. Intends for herself and her child to stay in Singapore for the next 2 years
  8. Access to a smartphone
  9. Willing to download the study app
  10. Score of 7 or more in the Edinburgh Postnatal Depression Scale

Fathers:

  1. 21-75 years of age
  2. Proficient and able to respond to questionnaires in English
  3. Intends for himself and his child to stay in Singapore for the next 2 years
  4. Access to a smartphone
  5. Willing to download the study app

Exclusion criteria

Exclusion Criteria:

Mothers:

  1. Any pre-existing or history of psychotic depression, schizophrenia, and bipolar disorders
  2. Currently on oral/IV and/or thyroid medication
  3. History of thyroid disease
  4. Pregnant using assisted reproductive technologies
  5. Multiple pregnancies
  6. Currently enrolled in interventional randomised controlled trials
  7. Responded "Yes, quite often" to EPDS item 10 ("The thought of harming myself has occurred to me")

Fathers:

1. Currently enrolled in interventional randomised controlled trials

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
572 participants (estimated)

Study arms

  • No intervention
    Group A (Control)

    Participants' will have access to a mobile app with similar functions as the participants in the intervention group, except that there are no personalized modules given. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

  • Experimental
    Group B (Intervention)

    Participants have access to the mHealth app that will be installed on their mobile devices and have access to weekly personalized recommendations. Data will also be collected from online and in-app surveys, as well as via the Fitbit watch.

    Behavioral: Group B (Intervention)

Interventions

  • BehavioralGroup B (Intervention)

    Participants in the intervention group will receive recommended modules in the mHealth app installed on their phones.

07

What researchers measure

Primary outcomes

  1. Parents' Depressive Symptoms

    Parents' level of depressive symptoms will be measured using the Edinburgh Postnatal Depression Scale.

    Time frame: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment

Secondary outcomes

  1. Parents' emotional regulation skills

    Examining self-reported parental emotional regulation skills using the Cognitive Emotion Regulation Questionnaire

    Time frame: Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months.

08

Study locations

1 of 1 sites recruiting
  • Institute for Human Development and Potential (IHDP), Singapore
    Singapore, 117609, Singapore
    Recruiting
    • Santhi Ponmudi, MPh · Contactsanthi_ponmudi@a-star.edu.sg · +65-64070100
    • Michelle Z.L Kee, PhD · Principal investigator
    • Cornelia Y.I Chee, MBBS, MMed · Principal investigator
    • Bibhas Chakraborty, PhD · Principal investigator
    • Xiaoxi Yan, PhD · Sub investigator
    • Evelyn C Law, MD · Sub investigator
09

References and documents

Individual participant data

Plan to share: Undecided — The decision regarding the availability of individual participant data for sharing requires further discussions between the institutes.

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2028, 29 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 29 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2026
First posted
Mar 19, 2026
StartActual
Jul 14, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jul 6, 2026→Jul 14, 2026 (actual)
Nov 6, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameParents' Depressive SymptomsAdministered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. A composite outcome of the three postnatal EPDS measurements will be used as a primary outcome assessment → Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Start date Jul 6, 2026→Jul 14, 2026 (now actual)
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameParents' Depressive SymptomsAdministered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. A composite outcome of the three postnatal EPDS measurements will be used as a primary outcome assessment → Administered upon enrollment, once at 21-24 gestation weeks, once at 28-32 weeks, once at 37-40 gestation weeks, and postnatal 1-, 3-, and 6-months. The average of the three postnatal EPDS measurements will be used as the primary outcome assessment

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT07483515
Lead sponsor
Institute for Human Development and Potential (IHDP), Singapore
Collaborators
Duke-NUS Graduate Medical School, National University of Singapore
Responsible party
Michelle Kee (Principal Scientist, Institute for Human Development and Potential (IHDP), Singapore) — Principal investigator
First posted
Mar 19, 2026
Start date
Jul 14, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Santhi Ponmudi, MPh
Contact
santhi_ponmudi@a-star.edu.sg
+65-64070100
Michelle Z.L Kee, PhD
principal investigator · Institute for Human Development and Potential

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion